List of bibliographic references
Number of relevant bibliographic references: 2.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 2 | Ankylosing |
| 2 | Ankylosing spondylitis |
| 2 | Arthritis rheum |
| 2 | Asas |
| 2 | Asas recommendations |
| 2 | Blocker |
| 2 | Braun |
| 2 | Chronic |
| 2 | Erythrocyte sedimentation rate |
| 2 | Expert opinion |
| 2 | Heijde |
| 2 | Infliximab |
| 2 | MRI, magnetic resonance imaging |
| 2 | Magnetic resonance imaging |
| 2 | Necrosis |
| 2 | Nsaid |
| 2 | Rheum |
| 2 | Rheumatology |
| 2 | Spondylitis |
| 2 | TNF, tumour necrosis factor |
| 2 | Tumour necrosis factor |
| 1 | AS, ankylosing spondylitis |
| 1 | ASAS |
| 1 | ASAS, ASsessment in AS |
| 1 | ASAS, ASsessment in Ankylosing Spondylitis |
| 1 | Active ankylosing spondylitis |
| 1 | Active disease |
| 1 | Adverse effects |
| 1 | Andersson lesion |
| 1 | Antibody infliximab |
| 1 | Antinuclear antibodies |
| 1 | Antirheumatic drugs |
| 1 | Arthritis |
| 1 | Arthroplasty |
| 1 | Asas core |
| 1 | Axial |
| 1 | Axial disease |
| 1 | BASDAI, Bath Ankylosing Spondylitis Disease Activity Index |
| 1 | Basdai |
| 1 | Basdai criterion |
| 1 | Basdai score |
| 1 | Basdai scores |
| 1 | Bath ankylosing spondylitis |
| 1 | Bath ankylosing spondylitis disease activity index |
| 1 | Beneficial effect |
| 1 | Best evidence |
| 1 | Biological agents |
| 1 | Biological treatment |
| 1 | CI, confidence interval |
| 1 | Calin |
| 1 | Cardiovascular |
| 1 | Cardiovascular events |
| 1 | Chest expansion |
| 1 | Clinical experience |
| 1 | Clinical expertise |
| 1 | Clinical findings |
| 1 | Clinical parameters |
| 1 | Clinical presentation |
| 1 | Clinical record |
| 1 | Clinical response |
| 1 | Clinical trials |
| 1 | Cochrane database syst |
| 1 | Comparative studies |
| 1 | Concomitant |
| 1 | Concomitant drugs |
| 1 | Confidence interval |
| 1 | Congestive heart failure |
| 1 | Continuous treatment |
| 1 | Conventional treatments |
| 1 | Corrective osteotomy |
| 1 | Corticosteroid |
| 1 | Corticosteroid injections |
| 1 | Cost effectiveness |
| 1 | Coxibs |
| 1 | Current manifestations |
| 1 | Current symptoms |
| 1 | DMARD, disease-modifying antirheumatic drug |
| 1 | DMARDs, disease modifying antirheumatic drugs |
| 1 | Demographic characteristics |
| 1 | Disease activity |
| 1 | Disease monitoring |
| 1 | Disease progression |
| 1 | Dmards |
| 1 | Dougados |
| 1 | Drug treatment |
| 1 | ES, effect size |
| 1 | EULAR |
| 1 | Effect size |
| 1 | Enthesitis |
| 1 | Etanercept |
| 1 | Eular |
| 1 | Eular recommendations |
| 1 | Evidence hierarchy |
| 1 | Expert group |
| 1 | First line drug treatment |
| 1 | Functional improvement |
| 1 | Gastroprotective agent |
| 1 | Gastroprotective agents |
| 1 | Heart failure |
| 1 | High disease activity |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "E. Collantes"
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i \
-Sk "E. Collantes" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Canada
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= E. Collantes
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
